STAT
SEPTEMBER 20, 2023
The federal government is again offering free Covid-19 tests to Americans, providing a fifth round of free tests in part to meet current needs, in part to stimulate a domestic testing industry that has struggled with cratering demand for the rapid diagnostics. The measure, announced Wednesday, will see rapid tests released from the Strategic National Stockpile.
PharmaVoice
SEPTEMBER 20, 2023
The saga of the anti-parasitic drug continues.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 20, 2023
More than three years into the coronavirus pandemic, fewer and fewer people are experiencing their first Covid-19 infections. But as cases climb , those who’ve had the virus before may wonder: What are their chances of developing long Covid — and does the risk increase with each reinfection? Fatigue and brain fog may be the first post-infection symptoms that come to mind for long Covid, but lists compiled by the Centers for Disease Control and Prevention and by the World Health Org
The Pharmacist
SEPTEMBER 20, 2023
More than 80,000 patients across mid and south Essex are now monitoring their blood pressure at home as part of an NHS scheme, according to a study by Essex University. BP@home, which was launched nationally in 2020, allows people to monitor their own blood pressure and submit readings to their GP by telephone and email […] The post Home blood pressure service 'success' in Essex appeared first on The Pharmacist.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
SEPTEMBER 20, 2023
Open wide, AI wants a look inside your mouth. A new wave of software is promising to supercharge dentists’ ability to spot decay and bone loss — and propose treatments earlier in the disease process. In just the past three years, eight AI products have gained approval from the Food and Drug Administration. Many more are on the way. These tools in some cases identify lesions years before dentists can see them on X-rays and other images, providing increased treatment opportunities ba
PharmExec
SEPTEMBER 20, 2023
The current vaccine pipeline brings promise of significant global health advancements—yet development gaps remain, and the future delivery challenges must be considered.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Digital Pharmacist
SEPTEMBER 20, 2023
The Medicare Open Enrollment period for 2024 is quickly approaching – this is a critical time for both your patients and your pharmacy. Every year, the enrollment period runs from October 15 to December 7. This leaves very little time before patients need to re-evaluate their insurance. Below is a breakdown of what you need to be aware of when assisting patients with 2024 open enrollments, as well as a few tips on how your pharmacy can prepare for this busy time at the pharmacy.
STAT
SEPTEMBER 20, 2023
Apellis Pharmaceuticals has been slowly rebounding from an unjustified safety scare related to its approved treatment for a common type of vision loss. Now, a competing medicine from Astellas, also recently approved, may have stumbled, which could further boost Apellis’ business outlook — and its stock price. In a statement released Monday night, Astellas announced the “positive” outcome of an important follow-up analysis meant to demonstrate the two-year efficacy of
Pharma Times
SEPTEMBER 20, 2023
Around 340,000 to 444,000 people in the UK carry one of nine pathogenic gene variants - News - PharmaTimes
STAT
SEPTEMBER 20, 2023
T wo months ago, Sen. Bernie Sanders (I-Vt.) moved a step closer to an idea he has championed for some time — awarding prizes, instead of patents, for inventing medicines. A measure was passed directing the National Academies of Sciences, Engineering, and Medicine to study the idea and was added to the Pandemic and All-Hazards Preparedness Act.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
BioPharma Dive
SEPTEMBER 20, 2023
Targeted protein degradation has emerged as one of the more competitive areas of pharmaceutical research in recent years as scientists develop new ways to reach difficult-to-drug targets.
STAT
SEPTEMBER 20, 2023
ARS Pharma had high hopes that the FDA on Tuesday would approve its flagship product, a needle-free treatment for adults and children with severe allergic reactions. But instead, the drugmaker was set back with the agency requesting an additional study. Neffy, as the product is called, is a nasal spray that delivers the same drug, epinephrine, as the auto-injectors currently used to treat anaphylaxis.
Pharmaceutical Technology
SEPTEMBER 20, 2023
The neurotech will receive the investment in Series B equity financing round to invest in Alzheimer’s disease research.
STAT
SEPTEMBER 20, 2023
As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. for selling unapproved versions of its Mounjaro diabetes drug, which is frequently used for combating obesity. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.
The Pharmacist
SEPTEMBER 20, 2023
A shortage of pharmacists and pharmacy technicians working in Scotland’s GP-based pharmacotherapy service needs to be urgently addressed, the Royal Pharmaceutical Society (RPS) director for Scotland has told The Pharmacist. Laura Wilson also highlighted the need for long-term workforce planning for pharmacy staff, akin to current work being done by the Scottish Government around planning […] The post Exclusive: Scotland’s pharmacotherapy service needs long-term workforce planning appeared
STAT
SEPTEMBER 20, 2023
Americans who suffer severe allergic reactions won’t have alternatives to autoinjectors like the Epipen for a while longer. In a surprise move, the Food and Drug Administration on Tuesday declined to approve neffy , an epinephrine nasal spray. Instead, the FDA asked the drug’s manufacturer, ARS Pharma, to conduct further studies, specifically comparing the effect of repeat doses of epinephrine administered via nasal spray versus auto-injection in people with allergic rhinitis, or h
Express Pharma
SEPTEMBER 20, 2023
Biocon Biologics has received the European Commission (EC) granted marketing authorization in the European Union (EU) for YESAFILI, a biosimilar of Aflibercept. The EC decision follows the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) positive opinion recommending approval of YESAFILI in July. YESAFILI , an ophthalmology product, is intended for the treatment of neovascular (wet AMD) age-related macular degeneration, visual impairment due to macular oedema sec
STAT
SEPTEMBER 20, 2023
Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI , they say. In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electro
Pharmacy Joe
SEPTEMBER 20, 2023
In this episode, I’ll discuss the danger of intubation in the setting of salicylate toxicity. episode854 Subscribe on iTunes , Android , or Stitcher During salicylate toxicity, the movement of salicylate into brain, liver, and other tissues is exacerbated by a low serum pH. This is because the more acidic the pH, the more salicylate becomes nonionized, and the nonionized form is what passes readily into tissues.
STAT
SEPTEMBER 20, 2023
For the fourth time this year, Novartis has been reprimanded by a U.K. trade group for misleading promotional efforts for its biggest-selling drug and, in the process, failing to maintain high standards expected of pharmaceutical companies. In the latest instance, the company was cited for hosting an online event to discuss heart failure but the virtual meeting essentially amounted to a promotional event, since Novartis medicines — specifically, the Entresto heart failure treatment ȁ
Pharma Times
SEPTEMBER 20, 2023
The universal vaccine could protect people against more strains of flu - News - PharmaTimes
STAT
SEPTEMBER 20, 2023
The small box full of promises arrived at Jessica Anderson’s home on her 31st birthday. A little bigger than a postcard, it was white with green lettering and navy and fuchsia flourishes. She opened it and pulled out a card with pills arrayed in plastic bubbles, coral ones for the morning, baby-blue for the evening. The culmination of decades of research, a reservoir of hope for thousands, these oblong tablets were supposed to transform her life, a life circumscribed by illness and the sp
Express Pharma
SEPTEMBER 20, 2023
Eli Lilly received approval for its dual glucagon-like peptide-1 receptor agonist (GLP-1)/gastric inhibitor polypeptide receptor agonist (GIP) therapy Mounjaro (tirzepatide) in August 2023 for use as a new treatment option for patients in England with type 2 diabetes (T2D), in cases where the existing treatment management options are insufficient. With the recent clinical data that has come out of both the SURMOUNT and SURPASS trials for both T2D and obesity, it is likely that Mounjaro will beco
STAT
SEPTEMBER 20, 2023
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Enough talk about fairness, safety, and effectiveness. If we want AI systems to possess these attributes in health care, we have to test them with those goals in mind.
European Pharmaceutical Review
SEPTEMBER 20, 2023
Results of a Phase I/II study has revealed that a booster dose of a novel, self-amplifying messenger RNA (sa-mRNA) COVID-19 vaccine induces a robust, broadly cross-reactive, and durable immune response in adults. Three sa-mRNA vaccines used in the clinical trial enabled participants to maintain elevated immune response through 12 months post-vaccination.
STAT
SEPTEMBER 20, 2023
Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today is chocolate raspberry — and get started. To help you along, we have assembled another menu of tidbits for you to peruse.
Express Pharma
SEPTEMBER 20, 2023
The National Company Law Appellate Tribunal (NCLAT), Delhi has delivered its decision regarding the contentious insolvency case concerning Hindustan National Glass. The NCLAT has upholded the entire insolvency resolution process followed by the Resolution Professional and endorsed by the Committee of Creditors (COC). This ruling follows a series of appeals brought before the NCLAT by various parties such as Independent Sugar Corporation and others.
STAT
SEPTEMBER 20, 2023
Northeastern University has been selected for a leading role in a new national network formed to better forecast the spread of a future pandemic. The university announced Tuesday the US Centers for Disease Control and Prevention has awarded it $17.5 million over the next five years to develop a center focused on detecting and preparing for the next outbreak of infectious disease, especially in rural areas.
The Pharmacist
SEPTEMBER 20, 2023
A national NHS campaign will launch this month to help patients 'not to be alarmed' if they contact their GP and are booked in for an appointment with a pharmacist. NHS England said the campaign would include ‘PR activity to generate content and consumer media coverage to increase patients’ knowledge and confidence in the primary […] The post NHS England campaign aims to ‘increase patient confidence’ in practice pharmacists appeared first on The Pharmacist.
Express Pharma
SEPTEMBER 20, 2023
Boehringer Ingelheim India has entered into a Memorandum of Understanding (MoU) with Pet Practitioners Association of Mumbai, a non-profit charitable organisation to combat rabies in the Greater Mumbai area. The free vaccination camps will be run with support of Brihanmumbai Municipal Corporation (BMC). The ‘Stop Rabies’ initiative aligns with India’s National Action Plan for Dog-Mediated Rabies Elimination by 2030.
The Pharmacist
SEPTEMBER 20, 2023
More should be done to ‘support collaboration’ rather than ‘fostering competition’ between different parts of the primary care system, a new report released this week by The King’s Fund and Nuffield Health has said. ‘Frontline’ clinical staff working in primary care such as in community pharmacies and general practice should instead be seen as part […] The post 'Support collaboration’ between community pharmacists and general practice, report urges appeared first on The Pharmacist.
Pharmaceutical Technology
SEPTEMBER 20, 2023
Merck KGaA announced plans to join forces with BenevolentAI and Exscientia to leverage their AI-driven drug discovery platforms.
pharmaphorum
SEPTEMBER 20, 2023
Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals Phil.
Outsourcing Pharma
SEPTEMBER 20, 2023
This week's woman in science, is Maria Pereira, who leads the Innovation Hub at TISSIUM, a Paris-based medtech startup that develops solutions for tissue reconstruction.
World Pharma News
SEPTEMBER 20, 2023
A cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients, thanks to new research at Hudson Institute of Medical Research. The body's inflammatory response to infection is important in controlling viruses, such as SARS-CoV-2, the virus that causes COVID-19, but when inflammation gets out of control the effects can be lethal.
Expert insights. Personalized for you.
364 
Let's personalize your content